Evidence map›Paper›PMID 29949471›Full record

ArticleNanomedicine (London, England)2018

Dose-, treatment- and time-dependent toxicity of superparamagnetic iron oxide nanoparticles on primary rat hepatocytes.

Kurtulus Gokduman, Furkan Bestepe, Lei Li, Martin L Yarmush, O Berk Usta

Abstract read
In one paragraph

Article in Nanomedicine (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Evaluation of drug carrier hepatotoxicity using primary cell culture models.Nanomedicine : nanotechnology, biology, and medicine · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. SiOMolecules (Basel, Switzerland) · 2020
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kurtulus GokdumanCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals, Boston, MA 02114, USA.
Furkan BestepeCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals, Boston, MA 02114, USA.
Lei LiCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals, Boston, MA 02114, USA.
Martin L YarmushCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals, Boston, MA 02114, USA.
O Berk UstaCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals, Boston, MA 02114, USA.

Funding

Bio-MicroElectroMechanical Systems Resource CenterP41EB002503 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI TONER, MEHMET · 2004 to 2018
$17.4M
Real Time Elucidation of Drug-Drug Interactions via Dual Reporter Cell Technology and Microfabricated ArraysR01EB023812 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI TONER, MEHMET, YARMUSH, MARTIN L · 2016 to 2019
$1.8M
Novel Microfluidic Platforms for Actively Controlled in-vitro Liver ZonationR21EB020192 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI USTA, OSMAN BERK · 2015 to 2016
$479k
NIBIB NIH HHS P41 EB002503NIBIB NIH HHS R01 EB023812NIBIB NIH HHS R21 EB020192NIH HHS 1R21EB020192NIH HHS 5P41EB002503NIH HHS 5R01EB023812
6 · The paper itself

Abstract

aimAs a first study in literature, to investigate concentration-dependent (0-400 μg/ml) and exposure-dependent (single dosing vs cumulative dosing) effects of superparamagnetic iron oxide nanoparticles (d = 10 nm) on primary rat hepatocytes in a time-dependent manner. MATERIALS &

methodsSandwich-cultured hepatocyte model was used to evaluate viability, hepatocyte specific functions and reactive oxygen species level.

resultsIn terms of all parameters, generally statistically more significant effects were observed in a concentration- and time-dependent manner. In terms of hepatocyte-specific functions, cumulative dosing caused significantly (p < 0.05) more deleterious effects at 48th hour.

conclusionA combination of various biomarkers should be employed for the evaluation of the effect of superparamagnetic iron oxide nanoparticles on liver, and each biomarker should be analyzed in a time- and exposure-dependent manner.

Indexed as

AnimalsCell SurvivalDose-Response Relationship, DrugFerric CompoundsHepatocytesLiverMagnetite NanoparticlesOxidative StressPrimary Cell CultureRatsReactive Oxygen SpeciesFerric Compoundsferric oxideMagnetite NanoparticlesReactive Oxygen Speciesalbuminprimary rat hepatocytesreactive oxygen species (ROS)superparamagnetic iron oxide nanoparticles (SPION)urea

Identifiers

PMID29949471
PMCPMC6219434

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.